naringenin and Pancreatic Neoplasms

naringenin has been researched along with Pancreatic Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's5 (71.43)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Awale, S; Esumi, H; Kadota, S; Li, F; Onozuka, H; Tezuka, Y1
Awale, S; Esumi, H; Kadota, S; Li, F; Tezuka, Y1
Akhter, MH; Kumar, S; Nomani, S1
Kim, DH; Kim, JH; Lee, J1
Choi, YJ; Lee, JH; Nam, MJ; Park, HJ1
Abrantes, M; Duarte, N; Ferreira, MJ; Lage, H1
Fang, X; Liang, W; Lou, C; Yang, M; Zeng, W; Zhang, C; Zhang, F; Zhang, Y; Zhao, J1

Other Studies

7 other study(ies) available for naringenin and Pancreatic Neoplasms

ArticleYear
Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition.
    Bioorganic & medicinal chemistry, 2008, Jan-01, Volume: 16, Issue:1

    Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Necrosis; Nutritional Requirements; Pancreatic Neoplasms; Phytotherapy; Plant Extracts; Propolis; Sensitivity and Specificity

2008
Study on the constituents of Mexican propolis and their cytotoxic activity against PANC-1 human pancreatic cancer cells.
    Journal of natural products, 2010, Apr-23, Volume: 73, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Bees; Drug Screening Assays, Antitumor; Flavonoids; Humans; Mexico; Molecular Structure; Pancreatic Neoplasms; Propolis; Stereoisomerism

2010
Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and
    Drug development and industrial pharmacy, 2020, Volume: 46, Issue:4

    Topics: Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Liberation; Drug Screening Assays, Antitumor; Drug Stability; Flavanones; Humans; Nanoparticles; Pancreatic Neoplasms; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Sonication

2020
Combined administration of naringenin and hesperetin with optimal ratio maximizes the anti-cancer effect in human pancreatic cancer via down regulation of FAK and p38 signaling pathway.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2019, Volume: 58

    Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Citrus; Down-Regulation; Flavanones; Focal Adhesion Kinase 1; Hesperidin; Humans; MAP Kinase Signaling System; Mice, Inbred BALB C; Pancreatic Neoplasms; Phosphorylation; Xenograft Model Antitumor Assays

2019
Naringenin causes ASK1-induced apoptosis via reactive oxygen species in human pancreatic cancer cells.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2017, Volume: 99

    Topics: Apoptosis; Blotting, Western; Electrophoresis, Gel, Two-Dimensional; Estrogen Antagonists; Flavanones; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 5; p38 Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Peptide Fragments; Peroxiredoxins; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation

2017
Phenolic compounds as selective antineoplasic agents against multidrug-resistant human cancer cells.
    Planta medica, 2010, Volume: 76, Issue:10

    Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Colonic Neoplasms; Drug Resistance, Multiple; Euphorbia; Flavanones; Humans; Lignans; Magnoliopsida; Myristicaceae; Neoplasms; Pancreatic Neoplasms; Phenols; Phytotherapy; Plant Extracts; Stilbenes; Stomach Neoplasms

2010
Naringenin decreases invasiveness and metastasis by inhibiting TGF-β-induced epithelial to mesenchymal transition in pancreatic cancer cells.
    PloS one, 2012, Volume: 7, Issue:12

    Topics: Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; Deoxycytidine; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Estrogen Antagonists; Flavanones; Gemcitabine; Humans; Neoplasm Invasiveness; Pancreatic Neoplasms; Phosphorylation; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta; Tumor Cells, Cultured; Wound Healing

2012